Codes / ICD10CM / T50.6X2D

T50.6X2D Poisoning by antidotes and chelating agents, intentional self-harm, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by antidotes and chelating agents, intentional self-harm, subsequent encounter

Summary

This condition involves harmful effects resulting from intentional self-harm exposure to antidotes or chelating agents during a subsequent encounter. It includes poisoning or adverse reactions due to deliberate ingestion or administration, which can disrupt physiological processes or exacerbate toxicity. Subsequent encounters indicate ongoing care after the initial episode.

Causes

Exposure may result from intentional ingestion of these agents, therapeutic errors (e.g., incorrect dosing), or interactions with other drugs affecting antidote/chelator efficacy. Underdosing can occur due to missed doses or inadequate prescription, while poisoning may stem from overdose or misuse. The event is classified as intentional self-harm in this scenario.

Risk Factors

  • Concurrent use of medications altering the metabolism or effect of antidotes/chelators
  • Renal or hepatic impairment affecting drug clearance
  • Elderly patients or those with impaired drug metabolism
  • Non-adherence to prescribed regimens
  • History of self-harm behaviors or mental health conditions

Symptoms

  • Variable depending on the specific agent (e.g., neurological effects from naloxone, renal toxicity from chelators)
  • Inadequate reversal of poisoning (e.g., persistent toxicity signs)
  • Adverse effects of the antidote/chelator (e.g., allergic reactions, electrolyte imbalances)
  • Underdosing-related symptoms matching the underlying condition (e.g., unresolved heavy metal toxicity)

Diagnosis

Diagnosis involves patient history to identify intentional exposure, physical examination for signs of toxicity, and laboratory tests (e.g., serum drug levels, electrolyte panels). Toxicology screening may help confirm exposure, and imaging or other tests may assess organ damage. Documentation of self-harm intent and subsequent encounter status is critical.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying toxicity. This may include supportive care, antidote administration (if appropriate), or chelation therapy. Psychiatric evaluation and intervention are essential for intentional self-harm cases. Ongoing monitoring and follow-up care are typically required.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, timely intervention, and underlying health status. Subsequent encounters allow for monitoring of recovery, management of complications, and adjustment of treatment plans. Follow-up care may involve repeated testing, medication adjustments, or continued psychiatric support to address self-harm risks.

Complications

  • Organ damage (e.g., renal or hepatic impairment from chelators)
  • Persistent toxicity or inadequate reversal of poisoning
  • Adverse reactions to antidotes or chelating agents
  • Recurrence of self-harm behaviors
  • Long-term psychological or physiological effects

Lifestyle & Prevention

  • Secure storage of medications to prevent intentional misuse
  • Education on proper use and risks of antidotes/chelators
  • Mental health support and crisis intervention for at-risk individuals
  • Regular follow-up with healthcare providers to monitor adherence and mental health
  • Avoidance of environmental exposure to chelating agents in occupational settings

When to Seek Professional Help

Seek immediate medical attention if intentional exposure to antidotes or chelating agents occurs, or if symptoms of poisoning (e.g., confusion, seizures, organ dysfunction) develop. Ongoing care during subsequent encounters requires prompt evaluation for complications or recurrence of self-harm behaviors.

Tips for Medical Coders

Document the intentional self-harm context and subsequent encounter status clearly. Ensure the code T50.6X2D is used only when the encounter is for ongoing care after the initial episode of intentional poisoning by antidotes or chelating agents. Verify that documentation supports the self-harm intent and subsequent encounter timing to align with coding guidelines.

Book a walkthrough

T50.6X2D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.